{{knowledge objective
|Identifiant=OIC-166-12-B
|Item_parent=Flu
|Item_parent_short=Flu
|Rank=B
|Title=Knowing specific treatments: indication, molecules
|Description=None
|Rubric=Management
|Contributors=
|Order=12}}
Indications :

- Oseltamivir: preventive or curative use in adults and children > 1 year old

- Zanamivir: preventive or curative use in adults and children > 5 years old

Objectives: to reduce the duration and intensity of symptoms

- Oseltamivir: Insufficient medical benefit since May 2020 for curative and preventive treatment during seasonal epidemics.

- Balance of benefits, risks and reimbursement discussed


Indications for neuraminidase inhibitors :

curative: people at risk, immediately severe flu, hospitalisations

preventive: immunodepressions, co-morbidities, people at risk of complications, groups of people at risk (institutionalised elderly people)

Undesirable effects: neuropsychiatric disorders, bronchospasm for the inhaled route and allergies.

<br />